Best-effort research profile: this record has not passed full two-source scientific verification. Descriptive fields, research protocols, storage/handling notes, and interaction guidance below are shown with their evidence labels, but calculator presets and exact dosing math remain hidden until the record is verified or reaches Community-Supported status.
Quick Facts
Reference Sizes
1 g, 10 g, 100 g
Storage
Store dry at room temperature in a tightly closed container
Solubility
Freely soluble in water
Best-Effort Research Profile
Inositol (particularly myo-inositol and D-chiro-inositol) is a cyclic sugar alcohol involved in cell-membrane phosphatidylinositol signaling and insulin-signal transduction. It has been studied clinically for polycystic ovary syndrome (PCOS)-related metabolic and reproductive outcomes, and in psychiatric research for mood-related applications.
Source review pending. This descriptive profile is shown from the available source material as a best-effort educational reference. It has not passed the full verification bar and is not a dosing instruction, medical claim, or treatment recommendation.
Research Profile
Half-Life
Form and population dependent; no single supplement half-life is suitable for the catalog
Onset
Metabolic and reproductive outcomes are generally assessed after weeks to months
Data source: Systematic review supporting the international evidence-based PCOS guideline
Reflects preclinical/research literature context only. Not a medical claim, dosing instruction, or treatment recommendation.
Route-Specific Research Protocols
Amounts and schedules are separated by administration route. Evidence badges distinguish labels, human studies, preclinical work, community reports, and evidence gaps.
Label / guidelineHuman studyCommunity onlyPreclinical onlyNot established
OralHuman study only
Trials use heterogeneous myo-inositol or D-chiro-inositol regimens commonly totaling 2-4 g daily
Frequency / timing
Once or twice daily
Duration / setting
Weeks to months
Technique
Oral
Evidence
Human study protocol
Context: PCOS systematic review PMID 38163998
Formulation: Oral-mucosal formulations are not dose-equivalent to injectable or topical formulations.
Route safety: Research-study protocol only; it is not an approved or individualized instruction and should not be extrapolated to another route.
Do not convert an amount between routes. Bioavailability, formulation, sterility, monitoring, and clinical context differ by route. Research-use context only; independently verify every cited source.
Research Interactions
Flagged Avoid / Caution Combinations (Research)
Assuming myo-inositol and D-chiro-inositol are dose-equivalent
Reflects patterns reported in research/community literature only. Not a safety guarantee, medical advice, or interaction warning for human use.
Research Notes
The 2023 international PCOS guideline evidence review found the efficacy evidence limited and inconclusive despite some potential benefits. The prior psychiatric 12-18 g entry lacked a direct citation and was removed.
Supplementary research context only. Not medical advice or a treatment recommendation.
Found a relevant Reddit or forum thread about this compound? Suggest it below. Every suggestion is reviewed by an editor before it appears -- nothing is published automatically.
Research Use Only. All content is for educational and research reference only. Not medical advice, a treatment recommendation, or guidance on human use. Compounds are not FDA-approved drugs unless specifically noted.